Epitranscriptomic Blood Biomarkers for Coronary Artery Disease - A Prospective Cohort Study (IHD-EPITRAN) (IHD-EPITRAN)
Epitranscriptomic Biomarkers for Ischemic Heart Disease (IHD-EPITRAN) - A Prospective Cohort Study
Sponsor: Folkhälsan Researech Center
This observational or N/A phase trial investigates Acute Myocardial Infarction and Aortic Valve Stenosis and is currently ongoing. Folkhälsan Researech Center leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
8 versions recorded-
Feb 2026 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Feb 2026 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2021 — Jul 2024 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Nov 2020 — Dec 2020 [monthly]
Not Yet Recruiting
-
Sep 2020 — Nov 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Folkhälsan Researech Center
- Hospital District of Helsinki and Uusimaa
- Karolinska Institutet
- Middle East Technical University
- Tays Heart Hospital
- University of Helsinki
- University of Tartu
For direct contact, visit the study record on ClinicalTrials.gov .